Nebula Research & Development LLC United Therapeutics Corp Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 4,584 shares of UTHR stock, worth $1.64 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
4,584Holding current value
$1.64 Million% of portfolio
0.19%Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
723Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$6.55 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.59 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$987 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$881 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...